Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC
David Pfister, Natalia Fernández Núñez, Anindita Sinha, Assaf Weiner, Aleksandra Deczkowska, Matthias Pinter, Olivier Govaere, Felicitas Müller, Quentin M. Anstee, T Entgleitner, Roland Rad, Roser Pinyol, Sara Torrecilla, Michael Dudek, Percy A. Knolle, Amy Weber, D Lengenhagger, Josep M. Llovet, Ido Amit, Felix Meissner, Burkhard Becher, Mathias Heikenwälder (2020). Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC. Zeitschrift für Gastroenterologie, 58(03), pp. e71-e71, DOI: 10.1055/a-1143-8420.
